生命科学资讯

Boehringer spells out a $448M future for Rectify's ABC kidney disease program

Hologic breast cancer study bolsters use of mammogram AI

Editor's corner: Fierce Medtech's top 10 stories of 2025 show how tech can treat

Gilead pays $35M to license pair of HSV assets from Assembly Bio pact

Is Illumina Inc Gaining or Losing Market Support? - Benzinga

Biopharma climbs higher as 9 drugmakers ink ‘pandering’ drug price deals with Trump

Windward gets bispecific from Qyuns in its second China deal of the year

Shionogi will pay $2.5B to acquire one of the only approved ALS drugs

Trump to test ‘most favored nation’ pricing for Medicare; Shionogi pays $2.5B for ALS drug

The Zacks Analyst Blog Highlights Walmart, Wells Fargo, Thermo Fisher Scientific, Seneca Foods and NetSol Technologies - Yahoo Finance

The Zacks Analyst Blog Highlights Walmart, Wells Fargo, Thermo Fisher Scientific, Seneca Foods and NetSol Technologies - Yahoo Finance Singapore

FDA says yes to Cytokinetics’ aficamten, now Myqorzo, in oHCM

Agilent Opens India Refurbishment Center for Sustainable Science - Environment+Energy Leader

Biggest gainers and losers for Dec. 15-19, 2025

The Zacks Analyst Blog Highlights Walmart, Wells Fargo, Thermo Fisher Scientific, Seneca Foods and NetSol Technologies - Zacks Investment Research

Ipsen gains access to ADC from Shanghai biotech Simcere Zaiming

10x Genomics (TXG) Maintains Buy Rating, Price Target Raised to $20 | TXG Stock News - GuruFocus

10x Genomics (TXG) Maintains Buy Rating, Price Target Raised to $20 | TXG Stock News - GuruFocus

Radiopharmaceutical specialist Aktis seeks an IPO

Illumina (NASDAQ:ILMN) Price Target Raised to $130.00 - MarketBeat